NCT06400472 2026-01-14A Study of LY4170156 in Participants With Selected Advanced Solid TumorsEli Lilly and CompanyPhase 1 Recruiting495 enrolled
NCT05431582 2023-06-15Phase I Study of ZN-c3 and Bevacizumab ± Pembrolizumab in Metastatic CCNE1 Amplified and TP53 Mutant Solid TumorsM.D. Anderson Cancer CenterPhase 1 Withdrawn